188 related articles for article (PubMed ID: 37117071)
1. Gynecological malignancies and obesity.
Agnew HJ; Kitson SJ; Crosbie EJ
Best Pract Res Clin Obstet Gynaecol; 2023 Jun; 88():102337. PubMed ID: 37117071
[TBL] [Abstract][Full Text] [Related]
2. The role of overweight and obesity in selected gynecological malignancies.
Markowska A; Stanisławiak-Rudowicz J; Jaszczyńska-Nowinka K
Eur J Gynaecol Oncol; 2017; 38(3):335-341. PubMed ID: 29693868
[TBL] [Abstract][Full Text] [Related]
3. The impact of obesity on the incidence and treatment of gynecologic cancers: a review.
Modesitt SC; van Nagell JR
Obstet Gynecol Surv; 2005 Oct; 60(10):683-92. PubMed ID: 16186785
[TBL] [Abstract][Full Text] [Related]
4. Obesity and female malignancies.
Benedetto C; Salvagno F; Canuto EM; Gennarelli G
Best Pract Res Clin Obstet Gynaecol; 2015 May; 29(4):528-40. PubMed ID: 25779915
[TBL] [Abstract][Full Text] [Related]
5. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Kaaks R; Lukanova A; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1531-43. PubMed ID: 12496040
[TBL] [Abstract][Full Text] [Related]
6. Obesity and gynecological cancers: A toxic relationship.
Wichmann IA; Cuello MA
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):123-134. PubMed ID: 34669205
[TBL] [Abstract][Full Text] [Related]
7. Estrogen therapy in gynecological cancer survivors.
Guidozzi F
Climacteric; 2013 Dec; 16(6):611-7. PubMed ID: 23952524
[TBL] [Abstract][Full Text] [Related]
8. The polycystic ovary syndrome and gynecological cancer risk.
Meczekalski B; Pérez-Roncero GR; López-Baena MT; Chedraui P; Pérez-López FR
Gynecol Endocrinol; 2020 Apr; 36(4):289-293. PubMed ID: 32103691
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progesterone in breast and gynecologic cancers. Etiology, therapeutic role, and hormone replacement.
Nason FG; Nelson BE
Obstet Gynecol Clin North Am; 1994 Jun; 21(2):245-70. PubMed ID: 7936544
[TBL] [Abstract][Full Text] [Related]
10. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
Kitson S; Ryan N; MacKintosh ML; Edmondson R; Duffy JM; Crosbie EJ
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012513. PubMed ID: 29388687
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for endometrial cancer.
Ali AT
Ceska Gynekol; 2013 Nov; 78(5):448-59. PubMed ID: 24313431
[TBL] [Abstract][Full Text] [Related]
12. Gynecological malignancy risk in colorectal cancer survivors: A population-based cohort study.
Chang WC; Muo CH; Liang JA; Sung FC; Kao CH
Eur J Oncol Nurs; 2015 Oct; 19(5):473-8. PubMed ID: 25790918
[TBL] [Abstract][Full Text] [Related]
13. Impact of endometriosis on risk of ovarian, endometrial and cervical cancers: a meta-analysis.
Li J; Liu R; Tang S; Feng F; Liu C; Wang L; Zhao W; Zhang T; Yao Y; Wang X; Sun C
Arch Gynecol Obstet; 2019 Jan; 299(1):35-46. PubMed ID: 30460611
[TBL] [Abstract][Full Text] [Related]
14. Impact of the COVID-19 Pandemic on Diagnosis and Management of Gynecological Cancer: A Single-Center Analysis.
Antunes D; Mendonça L; Melo Â; Gonçalves S; Nogueira Martins F; Nogueira Martins N
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557063
[TBL] [Abstract][Full Text] [Related]
15. Endometrial Cancer: Is This a New Disease?
Moore K; Brewer MA
Am Soc Clin Oncol Educ Book; 2017; 37():435-442. PubMed ID: 28561715
[TBL] [Abstract][Full Text] [Related]
16. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
[TBL] [Abstract][Full Text] [Related]
17. Environmental (nongenetic) factors in gynecological cancers: update and future perspectives.
Webb PM
Future Oncol; 2015; 11(2):295-307. PubMed ID: 25591840
[TBL] [Abstract][Full Text] [Related]
18. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
[TBL] [Abstract][Full Text] [Related]
19. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
20. The Association Between Nutrition, Obesity, Inflammation, and Endometrial Cancer: A Scoping Review.
Thrastardottir TO; Copeland VJ; Constantinou C
Curr Nutr Rep; 2023 Mar; 12(1):98-121. PubMed ID: 36513957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
